 |
 |

Prevention of Atrial Fibrillation Following Cardiac SurgeryReply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In Reply: Dr Arias points out that obesity, as measured by body mass index, may be an independent predictor of postoperative atrial tachyarrhythmias after cardiac surgery. Unfortunately, because the study database did not include height, analyses based on body mass index cannot be provided. However, the database did include weight. The median weight of the PAPABEAR (Prophylactic Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair) patients was 84 kg (interquartile range, 75-96 kg). In patients randomized to placebo therapy, there was no difference in the probability of developing a postoperative atrial tachyarrhythmia in patients weighing more than 84 kg (28.2%) compared with those weighing 84 kg or less (29.9%). Similarly, comparing the hazard ratios (HRs) for atrial tachyarrhythmia in patients with amiodarone treatment and those with placebo, there was no significant difference between patients weighing more than 84 kg (HR, 0.40; 95% confidence . . . [Full Text of this Article]
L. Brent Mitchell, MD
brent.mitchell@calgaryhealthregion.ca Department of Cardiac Sciences University of Calgary/Calgary Health Region
Derek V. Exner, MD, MPH
Libin Cardiovascular Institute of Alberta Calgary, Alberta
RELATED ARTICLES
Prevention of Atrial Fibrillation Following Cardiac Surgery
Miguel A. Arias
JAMA. 2006;295(19):2247.
EXTRACT
| FULL TEXT
Prevention of Atrial Fibrillation Following Cardiac Surgery
Brian J. Potter and Jacques LeLorier
JAMA. 2006;295(19):2247.
EXTRACT
| FULL TEXT
Prevention of Atrial Fibrillation Following Cardiac Surgery
Madan M. Kwatra
JAMA. 2006;295(19):2247-2248.
EXTRACT
| FULL TEXT
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial
L. Brent Mitchell, Derek V. Exner, D. George Wyse, Carol J. Connolly, Gregory D. Prystai, Alexander J. Bayes, William T. Kidd, Teresa Kieser, John J. Burgess, André Ferland, Charles L. MacAdams, and Andrew Maitland
JAMA. 2005;294(24):3093-3100.
ABSTRACT
| FULL TEXT
|